Close Menu

NEW YORK (GenomeWeb) – QuantuMDx and German microarray firm Scienion today announced that they have partnered to commercialize QuantuMDx's multiplexed nanowire array technology.

The nanowire technology is a component of QuantuMDx's Q-Poc handheld molecular diagnostic device. Molecular probes are printed on each nanowire in the array, raising multiplex potential.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The nonprofit Biden Cancer Initiative is suspending its operations, according to the Associated Press.

Researchers examine how white nationalists handle personal genetic ancestry results that conflict with their racist worldview, the New York Times reports.

NPR speaks with research participants before and after they learn their APOE E4 status, which affects their risk of developing Alzheimer's disease.

In PLOS this week: genetic characterization of Toxoplasma gondii strains, Crimean-Congo Hemorrhagic Fever Virus uncovered in Sudan, and more.